Geeta Gulati

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Response by Omland et al to Letter Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial".

Response by Omland et al to Letter Regarding Article, "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial".

Journal: Circulation

Published: June 01, 2026

Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy.

Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy.

Journal: JACC. CardioOncology

Published: March 04, 2026

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments. A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Journal: European heart journal. Cardiovascular Imaging

Published: December 01, 2025

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC.

Journal: European heart journal. Cardiovascular Imaging

Published: December 01, 2025

Cardio-Oncology: Risk Stratification, Guideline Recommendations, and Exemplifications in Breast Cancer and Chronic Lymphatic Leukemia - An ad hoc Expert Opinion.

Cardio-Oncology: Risk Stratification, Guideline Recommendations, and Exemplifications in Breast Cancer and Chronic Lymphatic Leukemia - An ad hoc Expert Opinion.

Journal: Cardiology

Published: October 02, 2025

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.

Journal: Circulation

Published: August 30, 2025

Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients.

Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients.

Journal: JACC. Advances

Published: August 11, 2025

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects.

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects.

Journal: Journal of clinical pharmacology

Published: April 08, 2025

Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology.

Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology.

Journal: European journal of heart failure

Published: February 21, 2025

Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial.

Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial.

Journal: JACC. CardioOncology

Published: September 06, 2024

The Nordic Cardio-Oncology Society: mission and future goals.

The Nordic Cardio-Oncology Society: mission and future goals.

Journal: European heart journal

Published: April 12, 2024

Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.

Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.

Journal: European journal of heart failure

Published: November 12, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026